CN1141292C - 细胞生长抑制剂 - Google Patents

细胞生长抑制剂 Download PDF

Info

Publication number
CN1141292C
CN1141292C CNB988138476A CN98813847A CN1141292C CN 1141292 C CN1141292 C CN 1141292C CN B988138476 A CNB988138476 A CN B988138476A CN 98813847 A CN98813847 A CN 98813847A CN 1141292 C CN1141292 C CN 1141292C
Authority
CN
China
Prior art keywords
hydroxycarbamoyl
methyl
hex
enoylamino
isobutyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB988138476A
Other languages
English (en)
Chinese (zh)
Other versions
CN1286681A (zh
Inventor
L��A��Ƥ��ѷ
L·A·皮尔逊
A·P·艾斯库
P·赫克斯利
A·H·德吕蒙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
British Biotech Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharmaceuticals Ltd filed Critical British Biotech Pharmaceuticals Ltd
Publication of CN1286681A publication Critical patent/CN1286681A/zh
Application granted granted Critical
Publication of CN1141292C publication Critical patent/CN1141292C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
CNB988138476A 1998-03-12 1998-03-12 细胞生长抑制剂 Expired - Lifetime CN1141292C (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB1998/000754 WO1999046241A1 (en) 1998-03-12 1998-03-12 Cytostatic agents

Publications (2)

Publication Number Publication Date
CN1286681A CN1286681A (zh) 2001-03-07
CN1141292C true CN1141292C (zh) 2004-03-10

Family

ID=10825272

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB988138476A Expired - Lifetime CN1141292C (zh) 1998-03-12 1998-03-12 细胞生长抑制剂

Country Status (17)

Country Link
EP (1) EP1062202B1 (enExample)
JP (1) JP4324324B2 (enExample)
KR (1) KR20010041661A (enExample)
CN (1) CN1141292C (enExample)
AT (1) ATE231122T1 (enExample)
AU (1) AU747977B2 (enExample)
BR (1) BR9815717A (enExample)
CA (1) CA2323414C (enExample)
CZ (1) CZ299610B6 (enExample)
DE (1) DE69810817T2 (enExample)
GB (1) GB2349149A (enExample)
HU (1) HUP0100999A2 (enExample)
IL (2) IL137774A0 (enExample)
NO (1) NO20004528D0 (enExample)
NZ (1) NZ506293A (enExample)
PL (1) PL190637B1 (enExample)
WO (1) WO1999046241A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9901863D0 (en) * 1999-01-29 1999-03-17 British Biotech Pharm Antibacterial agents
WO2019039937A1 (en) 2017-08-21 2019-02-28 Stichting Vumc POLYTHERAPY FOR THE TREATMENT OF CANCER
US10925851B2 (en) 2018-03-15 2021-02-23 Regents Of The University Of Minnesota Use of Tosedostat and related compounds as analgesics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021942A2 (en) * 1992-05-01 1993-11-11 British Biotech Pharmaceuticals Limited Use of mmp inhibitors
GB9215665D0 (en) * 1992-07-23 1992-09-09 British Bio Technology Compounds
US5691381A (en) * 1995-04-18 1997-11-25 The Dupont Merck Pharmaceutical Company Hydroxamic and carbocyclic acids as metalloprotease inhibitors
CZ298048B6 (cs) * 1996-09-10 2007-06-06 British Biotech Pharmaceuticals Limited Farmaceutický prostredek a deriváty kyseliny hydroxamové

Also Published As

Publication number Publication date
WO1999046241A1 (en) 1999-09-16
PL342811A1 (en) 2001-07-02
JP2002506057A (ja) 2002-02-26
IL137774A0 (en) 2001-10-31
EP1062202A1 (en) 2000-12-27
HUP0100999A2 (hu) 2001-08-28
AU747977B2 (en) 2002-05-30
ATE231122T1 (de) 2003-02-15
CZ299610B6 (cs) 2008-09-17
CN1286681A (zh) 2001-03-07
NO20004528L (no) 2000-09-11
NO20004528D0 (no) 2000-09-11
AU6410698A (en) 1999-09-27
GB0019414D0 (en) 2000-09-27
NZ506293A (en) 2003-05-30
BR9815717A (pt) 2000-11-07
PL190637B1 (pl) 2005-12-30
KR20010041661A (ko) 2001-05-25
IL137774A (en) 2006-07-05
CZ20003317A3 (cs) 2001-03-14
CA2323414C (en) 2008-05-13
JP4324324B2 (ja) 2009-09-02
GB2349149A (en) 2000-10-25
EP1062202B1 (en) 2003-01-15
DE69810817D1 (de) 2003-02-20
DE69810817T2 (de) 2003-11-20
CA2323414A1 (en) 1999-09-16

Similar Documents

Publication Publication Date Title
CN1216047C (zh) 三环内酰胺和磺内酰胺衍生物和它们作为组蛋白脱乙酰基转移酶抑制剂的应用
CN1041203C (zh) 吡唑并吡啶化合物的制备方法
CN1305473A (zh) 抑制整联蛋白与其受体结合的n,n－二取代的酰胺
CN1372541A (zh) 磺酰基甲酰胺衍生物、其制备方法及其作为药物的应用
CN1376063A (zh) 环胺ccr3拮抗剂
CN1237180A (zh) 噻吩并－三唑并二氮杂䓬化合物及其医药用途
JP5061134B2 (ja) ２−フェニルベンゾチアゾリン誘導体またはその塩類からなるκオピオイド受容体アゴニスト
TW201305117A (zh) ［３－（１－（１ｈ－咪唑－４－基）乙基）－２－甲基苯基］甲醇之酯類前藥
CZ159197A3 (cs) Inhibitory metalloproteinázy, způsob jejich výroby a farmaceutický prostředek s jejich obsahem
CN1175944A (zh) 1－芳基－2－酰氨基乙烷化合物和它们作为神经激肽尤其是神经激肽1拮抗剂的用途
CN1072652C (zh) 取代的苯甲酰氨基噻唑衍生物以及含有它们的药物
CN1141292C (zh) 细胞生长抑制剂
CN1098841C (zh) 新颖的酰胺衍生物及其医药组合物
CN100338055C (zh) 2－杂环－1,2－乙二醇的氨基甲酸酯
JP2004002352A (ja) ２−フェニルベンゾチアゾリン誘導体からなるκオピオイド受容体アゴニスト
JP2004002352A6 (ja) ２−フェニルベンゾチアゾリン誘導体からなるκオピオイド受容体アゴニスト
RU2187499C2 (ru) Цитостатические агенты
CN1264365A (zh) 3－苯甲酰基吲哚衍生物及含有它们的药物
CN1132204A (zh) 新的杂环酰胺
WO2006095822A1 (ja) スルホンアミド化合物およびその医薬
CN1946712A (zh) 吡咯烷衍生物
CN1142496A (zh) 新噻吩化合物，它们的制备方法和含有它们的药物组合物
CN1580054A (zh) 五元硫杂环类化合物及其用于制备治疗和预防肥胖相关疾病的药物的用途
CN1346347A (zh) 环胺衍生物和它们的用途
JPH09188631A (ja) Ｆａｓリガンド可溶化抑制薬

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20040310